Hong Kong Wound Dressing Market Research Report: By Type (Advanced, Traditional), Application (Chronic Wounds, Acute Wounds), End User (Hospitals and Specialty Clinics, Homecare Settings, Long-Term-Care Settings), Distribution Channel (Pharmacies, Online Channels) - Industry Analysis and Revenue Estimation to 2030

Chapter 1. Research Background

1.1 Research Objectives

1.2 Market Definition

1.3 Research Scope

1.3.1 Market Segmentation by Type

1.3.2 Market Segmentation by Application

1.3.3 Market Segmentation by End User

1.3.4 Market Segmentation by Distribution Channel

1.3.5 Analysis Period

1.3.6 Market Data Reporting Unit

1.3.6.1 Value

1.4 Key Stakeholders

Chapter 2. Research Methodology

2.1 Secondary Research

2.1.1 Paid

2.1.2 Unpaid

2.1.3 P&S Intelligence Database

2.2 Primary Research

2.2.1 Breakdown of Primary Research, by Industry Participant

2.2.2 Breakdown of Primary Research, by Designation

2.2.3 Breakdown of Primary Research, by Company Type

2.3 Market Size Estimation

2.4 Data Triangulation

2.5 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

4.1 Market Definition

4.1.1 By Type

4.1.1.1 Advanced

4.1.1.1.1 Foam

4.1.1.1.2 Hydrocolloid

4.1.1.1.3 Film

4.1.1.1.4 Alginate

4.1.1.1.5 Antimicrobial

4.1.1.1.6 Hydrogel

4.1.1.1.7 Collagen

4.1.1.1.8 Hydrofiber

4.1.1.1.9 Wound contact layer

4.1.1.1.10 Superabsorbent

4.1.1.1.11 NPWT

4.1.1.1.12 Others

4.1.1.2 Traditional

4.1.1.2.1 Bandages

4.1.1.2.2 Gauzes

4.1.1.2.3 Sponges

4.1.1.2.4 Abdominal pads

4.1.1.2.5 Others

4.1.2 By Application

4.1.2.1 Chronic wounds

4.1.2.1.1 DFUs

4.1.2.1.2 VLUs

4.1.2.1.3 Pressure ulcers

4.1.2.1.4 Others

4.1.2.2 Acute wounds

4.1.2.2.1 Surgical and traumatic wounds

4.1.2.2.2 Burns

4.1.3 By End User

4.1.3.1 Hospitals and specialty clinics

4.1.3.1.1 Inpatient settings

4.1.3.1.2 Outpatient settings

4.1.3.2 Homecare settings

4.1.3.3 Long-term-care settings

4.1.4 By Distribution Channel

4.1.4.1 Pharmacies

4.1.4.2 Online channels

4.2 Market Dynamics

4.2.1 Trends

4.2.1.1 Shift in consumer preference from traditional products to advanced therapies

4.2.2 Drivers

4.2.2.1 Growing geriatric population

4.2.2.2 Increasing prevalence of diabetes

4.2.2.3 High incidence of traumatic injuries

4.2.2.4 Impact analysis of drivers on market forecast

4.2.3 Restraints

4.2.3.1 High cost of advanced wound dressing products

4.2.3.2 Impact analysis of restraints on market forecast

4.2.4 Opportunities

4.2.4.1 Improving economy and increasing health expenditure

4.2.4.2 Ineffectiveness of traditional wound dressings in acute wound management

4.3 Impact of COVID-19

4.4 Porter’s Five Forces Analysis

4.5 Regulatory Overview

4.6 Wound Dressing Product Pricing

Chapter 5. Hong Kong Market Size and Forecast

5.1 By Type

5.1.1 Advanced Wound Dressing Market, by Type

5.1.1.1 Foam dressing market

5.1.1.1.1 By hospital type

5.1.1.1.2 By prescription mode

5.1.1.2 Hydrocolloid dressing market

5.1.1.2.1 By hospital type

5.1.1.2.2 By prescription mode

5.1.1.3 Film dressing market

5.1.1.3.1 By hospital type

5.1.1.3.2 By prescription mode

5.1.1.4 Alginate dressing market

5.1.1.4.1 By hospital type

5.1.1.4.2 By prescription mode

5.1.1.5 Antimicrobial dressing market

5.1.1.5.1 By hospital type

5.1.1.5.2 By prescription mode

5.1.1.6 Hydrogel dressing market

5.1.1.6.1 By hospital type

5.1.1.6.2 By prescription mode

5.1.1.7 Collagen dressing market

5.1.1.7.1 By hospital type

5.1.1.7.2 By prescription mode

5.1.1.8 Hydrofiber dressing market

5.1.1.8.1 By hospital type

5.1.1.8.2 By prescription mode

5.1.1.9 Wound contact layer dressing market

5.1.1.9.1 By hospital type

5.1.1.9.2 By prescription mode

5.1.1.10 Superabsorbent dressing market

5.1.1.10.1 By hospital type

5.1.1.10.2 By prescription mode

5.1.1.11 NPWT dressing market

5.1.1.11.1 By hospital type

5.1.1.11.2 By prescription mode

5.1.2 Traditional Wound Dressing Market, by Type

5.2 By Application

5.2.1 Wound Dressing Market for Chronic Wounds, by Type

5.2.2 Wound Dressing Market for Acute Wounds, by Type

5.3 By End User

5.3.1 Wound Dressings for Hospital and Specialty Clinic Use, by Type

5.4 By Distribution Channel

Chapter 6. Strategic Developments by Key Players

6.1 Mergers and Acquisitions

6.2 Partnerships

6.3 Other Developments

Chapter 7. Company Profiles

7.1 Coloplast A/S

7.1.1 Business Overview

7.1.2 Product and Service Offerings

7.1.3 Key Financial Summary

7.2 3M Company

7.2.1 Business Overview

7.2.2 Product and Service Offerings

7.2.3 Key Financial Summary

7.3 Paul Hartmann AG

7.3.1 Business Overview

7.3.2 Product and Service Offerings

7.3.3 Key Financial Summary

7.4 Winner Medical Co. Ltd.

7.4.1 Business Overview

7.4.2 Product and Service Offerings

7.5 Mölnlycke Health Care AB

7.5.1 Business Overview

7.5.2 Product and Service Offerings

7.5.3 Key Financial Summary

7.6 Smith & Nephew plc

7.6.1 Business Overview

7.6.2 Product and Service Offerings

7.6.3 Key Financial Summary

7.7 ConvaTec Group plc

7.7.1 Business Overview

7.7.2 Product and Service Offerings

7.7.3 Key Financial Summary

7.8 Allmed Medical Products Co. Ltd.

7.8.1 Business Overview

7.8.2 Product and Service Offerings

7.9 Zhende Medical Co. Ltd.

7.9.1 Business Overview

7.9.2 Product and Service Offerings

7.10 Wayson Medical Co. Ltd.

7.10.1 Business Overview

7.10.2 Product and Service Offerings

7.11 B. Braun Melsungen AG

7.11.1 Business Overview

7.11.2 Product and Service Offerings

7.11.3 Key Financial Summary

7.12 Essity AB

7.12.1 Business Overview

7.12.2 Product and Service Offerings

7.12.3 Key Financial Summary

7.13 Beiersdorf AG

7.13.1 Business Overview

7.13.2 Product and Service Offerings

7.13.3 Key Financial Summary

7.14 Johnson & Johnson

7.14.1 Business Overview

7.14.2 Product and Service Offerings

7.14.3 Key Financial Summary

7.15 Urgo Medical

7.15.1 Business Overview

7.15.2 Product and Service Offerings

7.16 Cardinal Health Inc.

7.16.1 Business Overview

7.16.2 Product and Service Offerings

7.16.3 Key Financial Summary

7.17 Medtronic plc

7.17.1 Business Overview

7.17.2 Product and Service Offerings

7.17.3 Key Financial Summary

7.18 Integra LifeSciences Holdings Corporation

7.18.1 Business Overview

7.18.2 Product and Service Offerings

7.18.3 Key Financial Summary

7.19 Wright Medical Group N.V.

7.19.1 Business Overview

7.19.2 Product and Service Offerings

7.19.3 Key Financial Summary

7.20 Medela AG

7.20.1 Business Overview

7.20.2 Product and Service Offerings

7.21 Lohmann & Rauscher GmbH & Co. KG

7.21.1 Business Overview

7.21.2 Product and Service Offerings

7.22 Nitto Denko Corporation

7.22.1 Business Overview

7.22.2 Product and Service Offerings

7.22.3 Key Financial Summary

7.23 Weigao Group Co. Ltd.

7.23.1 Business Overview

7.23.2 Product and Service Offerings

7.23.3 Key Financial Summary

Chapter 8. Appendix

8.1 Abbreviations

8.2 Sources and References

8.3 Related Report

 

LIST OF TABLES

 

TABLE 1 ANALYSIS PERIOD OF THE STUDY

TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS

TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS

TABLE 4 PRICING OF SOME MAJORLY USED WOUND DRESSING PRODUCTS

TABLE 5 HONG KONG WOUND DRESSING MARKET, BY TYPE, $’000 (2019–2024)

TABLE 6 HONG KONG WOUND DRESSING MARKET, BY TYPE, $’000 (2025–2030)

TABLE 7 HONG KONG WOUND DRESSING MARKET, BY TYPE, $’000 (2025–2030)

TABLE 8 HONG KONG ADVANCED WOUND DRESSING MARKET, BY TYPE, $’000 (2019–2024)

TABLE 9 HONG KONG ADVANCED WOUND DRESSING MARKET, BY TYPE, $’000 (2025–2030)

TABLE 10 HONG KONG ADVANCED WOUND DRESSING MARKET, BY TYPE, $’000 (2025–2030)

TABLE 11 HONG KONG FOAM DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2019–2024)

TABLE 12 HONG KONG FOAM DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2025–2030)

TABLE 13 HONG KONG FOAM DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2025–2030)

TABLE 14 HONG KONG FOAM DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2019–2024)

TABLE 15 HONG KONG FOAM DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2025–2030)

TABLE 16 HONG KONG FOAM DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2025–2030)

TABLE 17 HONG KONG HYDROCOLLOID DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2019–2024)

TABLE 18 HONG KONG HYDROCOLLOID DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2025–2030)

TABLE 19 HONG KONG HYDROCOLLOID DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2025–2030)

TABLE 20 HONG KONG HYDROCOLLOID DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2019–2024)

TABLE 21 HONG KONG HYDROCOLLOID DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2025–2030)

TABLE 22 HONG KONG HYDROCOLLOID DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2025–2030)

TABLE 23 HONG KONG FILM DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2019–2024)

TABLE 24 HONG KONG FILM DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2025–2030)

TABLE 25 HONG KONG FILM DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2025–2030)

TABLE 26 HONG KONG FILM DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2019–2024)

TABLE 27 HONG KONG FILM DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2025–2030)

TABLE 28 HONG KONG FILM DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2025–2030)

TABLE 29 HONG KONG ALGINATE DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2019–2024)

TABLE 30 HONG KONG ALGINATE DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2025–2030)

TABLE 31 HONG KONG ALGINATE DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2025–2030)

TABLE 32 HONG KONG ALGINATE DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2019–2024)

TABLE 33 HONG KONG ALGINATE DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2025–2030)

TABLE 34 HONG KONG ALGINATE DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2025–2030)

TABLE 35 HONG KONG ANTIMICROBIAL DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2019–2024)

TABLE 36 HONG KONG ANTIMICROBIAL DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2025–2030)

TABLE 37 HONG KONG ANTIMICROBIAL DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2025–2030)

TABLE 38 HONG KONG ANTIMICROBIAL DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2019–2024)

TABLE 39 HONG KONG ANTIMICROBIAL DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2025–2030)

TABLE 40 HONG KONG ANTIMICROBIAL DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2025–2030)

TABLE 41 HONG KONG HYDROGEL DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2019–2024)

TABLE 42 HONG KONG HYDROGEL DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2025–2030)

TABLE 43 HONG KONG HYDROGEL DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2025–2030)

TABLE 44 HONG KONG HYDROGEL DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2019–2024)

TABLE 45 HONG KONG HYDROGEL DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2025–2030)

TABLE 46 HONG KONG HYDROGEL DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2025–2030)

TABLE 47 HONG KONG COLLAGEN DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2019–2024)

TABLE 48 HONG KONG COLLAGEN DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2025–2030)

TABLE 49 HONG KONG COLLAGEN DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2025–2030)

TABLE 50 HONG KONG COLLAGEN DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2019–2024)

TABLE 51 HONG KONG COLLAGEN DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2025–2030)

TABLE 52 HONG KONG COLLAGEN DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2025–2030)

TABLE 53 HONG KONG HYDROFIBER DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2019–2024)

TABLE 54 HONG KONG HYDROFIBER DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2025–2030)

TABLE 55 HONG KONG HYDROFIBER DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2025–2030)

TABLE 56 HONG KONG HYDROFIBER DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2019–2024)

TABLE 57 HONG KONG HYDROFIBER DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2025–2030)

TABLE 58 HONG KONG HYDROFIBER DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2025–2030)

TABLE 59 HONG KONG WOUND CONTACT LAYER DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2019–2024)

TABLE 60 HONG KONG WOUND CONTACT LAYER DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2025–2030)

TABLE 61 HONG KONG WOUND CONTACT LAYER DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2025–2030)

TABLE 62 HONG KONG WOUND CONTACT LAYER DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2019–2024)

TABLE 63 HONG KONG WOUND CONTACT LAYER DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2025–2030)

TABLE 64 HONG KONG WOUND CONTACT LAYER DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2025–2030)

TABLE 65 HONG KONG SUPERABSORBENT DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2019–2024)

TABLE 66 HONG KONG SUPERABSORBENT DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2025–2030)

TABLE 67 HONG KONG SUPERABSORBENT DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2025–2030)

TABLE 68 HONG KONG SUPERABSORBENT DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2019–2024)

TABLE 69 HONG KONG SUPERABSORBENT DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2025–2030)

TABLE 70 HONG KONG SUPERABSORBENT DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2025–2030)

TABLE 71 HONG KONG NPWT DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2019–2024)

TABLE 72 HONG KONG NPWT DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2025–2030)

TABLE 73 HONG KONG NPWT DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2025–2030)

TABLE 74 HONG KONG NPWT DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2019–2024)

TABLE 75 HONG KONG NPWT DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2025–2030)

TABLE 76 HONG KONG NPWT DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2025–2030)

TABLE 77 HONG KONG TRADITIONAL WOUND DRESSING MARKET, BY TYPE, $’000 (2019–2024)

TABLE 78 HONG KONG TRADITIONAL WOUND DRESSING MARKET, BY TYPE, $’000 (2025–2030)

TABLE 79 HONG KONG TRADITIONAL WOUND DRESSING MARKET, BY TYPE, UNITS (2025–2030)

TABLE 80 HONG KONG WOUND DRESSING MARKET, BY APPLICATION, $’000 (2019–2024)

TABLE 81 HONG KONG WOUND DRESSING MARKET, BY APPLICATION, $’000 (2025–2030)

TABLE 82 HONG KONG WOUND DRESSING MARKET, BY APPLICATION, $’000 (2025–2030)

TABLE 83 HONG KONG WOUND DRESSING MARKET FOR CHRONIC WOUNDS, BY TYPE, $’000 (2019–2024)

TABLE 84 HONG KONG WOUND DRESSING MARKET FOR CHRONIC WOUNDS, BY TYPE, $’000 (2025–2030)

TABLE 85 HONG KONG WOUND DRESSING MARKET FOR CHRONIC WOUNDS, BY TYPE, $’000 (2025–2030)

TABLE 86 HONG KONG WOUND DRESSING MARKET FOR ACUTE WOUNDS, BY TYPE, $’000 (2019–2024)

TABLE 87 HONG KONG WOUND DRESSING MARKET FOR ACUTE WOUNDS, BY TYPE, $’000 (2025–2030)

TABLE 88 HONG KONG WOUND DRESSING MARKET FOR ACUTE WOUNDS, BY TYPE, $’000 (2025–2030)

TABLE 89 HONG KONG WOUND DRESSING MARKET, BY END USER, $’000 (2019–2024)

TABLE 90 HONG KONG WOUND DRESSING MARKET, BY END USER, $’000 (2025–2030)

TABLE 91 HONG KONG WOUND DRESSING MARKET, BY END USER, $’000 (2025–2030)

TABLE 92 HONG KONG MARKET FOR WOUND DRESSINGS FOR HOSPITAL AND SPECIALTY CLINIC USE, BY TYPE, $’000 (2019–2024)

TABLE 93 HONG KONG MARKET FOR WOUND DRESSINGS FOR HOSPITAL AND SPECIALTY CLINIC USE, BY TYPE, $’000 (2025–2030)

TABLE 94 HONG KONG MARKET FOR WOUND DRESSINGS FOR HOSPITAL AND SPECIALTY CLINIC USE, BY TYPE, $’000 (2025–2030)

TABLE 95 HONG KONG WOUND DRESSING MARKET, BY DISTRIBUTION CHANNEL, $’000 (2019–2024)

TABLE 96 HONG KONG WOUND DRESSING MARKET, BY DISTRIBUTION CHANNEL, $’000 (2025–2030)

TABLE 97 HONG KONG WOUND DRESSING MARKET, BY DISTRIBUTION CHANNEL, $’000 (2025–2030)

TABLE 98 COLOPLAST A/S – AT A GLANCE

TABLE 99 COLOPLAST A/S – KEY FINANCIAL SUMMARY

TABLE 100 3M COMPANY – AT A GLANCE

TABLE 101 3M COMPANY – KEY FINANCIAL SUMMARY

TABLE 102 PAUL HARTMANN AG – AT A GLANCE

TABLE 103 PAUL HARTMANN AG – KEY FINANCIAL SUMMARY

TABLE 104 WINNER MEDICAL CO. LTD. – AT A GLANCE

TABLE 105 MÖLNLYCKE HEALTH CARE AB – AT A GLANCE

TABLE 106 MÖLNLYCKE HEALTH CARE AB – KEY FINANCIAL SUMMARY

TABLE 107 SMITH & NEPHEW PLC – AT A GLANCE

TABLE 108 SMITH & NEPHEW PLC – KEY FINANCIAL SUMMARY

TABLE 109 CONVATEC GROUP PLC – AT A GLANCE

TABLE 110 CONVATEC GROUP PLC – KEY FINANCIAL SUMMARY

TABLE 111 ALLMED MEDICAL PRODUCTS CO. LTD. – AT A GLANCE

TABLE 112 ZHENDE MEDICAL CO. LTD. – AT A GLANCE

TABLE 113 WAYSON MEDICAL CO. LTD. – AT A GLANCE

TABLE 114 B. BRAUN MELSUNGEN AG – AT A GLANCE

TABLE 115 B. BRAUN MELSUNGEN AG – KEY FINANCIAL SUMMARY

TABLE 116 ESSITY AB – AT A GLANCE

TABLE 117 ESSITY AB – KEY FINANCIAL SUMMARY

TABLE 118 BEIERSDORF AG – AT A GLANCE

TABLE 119 BEIERSDORF AG – KEY FINANCIAL SUMMARY

TABLE 120 JOHNSON & JOHNSON – AT A GLANCE

TABLE 121 JOHNSON & JOHNSON – KEY FINANCIAL SUMMARY

TABLE 122 URGO MEDICAL – AT A GLANCE

TABLE 123 CARDINAL HEALTH INC. – AT A GLANCE

TABLE 124 CARDINAL HEATH INC. – KEY FINANCIAL SUMMARY

TABLE 125 MEDTRONIC PLC – AT A GLANCE

TABLE 126 MEDTRONIC PLC – KEY FINANCIAL SUMMARY

TABLE 127 INTEGRA LIFESCIENCES HOLDINGS CORPORATION – AT A GLANCE

TABLE 128 INTEGRA LIFESCIENCES HOLDINGS CORPORATION – KEY FINANCIAL SUMMARY

TABLE 129 WRIGHT MEDICAL GROUP N.V. – AT A GLANCE

TABLE 130 WRIGHT MEDICAL GROUP N.V. – KEY FINANCIAL SUMMARY

TABLE 131 MEDELA AG – AT A GLANCE

TABLE 132 LOHMANN & RAUSCHER GMBH & CO. KG – AT A GLANCE

TABLE 133 NITTO DENKO CORPORATION – AT A GLANCE

TABLE 134 NITTO DENKO CORPORATION – KEY FINANCIAL SUMMARY

TABLE 135 WEIGAO GROUP CO. LTD. – AT A GLANCE

TABLE 136 WEIGAO GROUP CO., LTD. – KEY FINANCIAL SUMMARY

 

LIST OF FIGURES

 

FIG 1 RESEARCH SCOPE

FIG 2 RESEARCH METHODOLOGY

FIG 3 BREAKDOWN OF PRIMARY RESEARCH, BY INDUSTRY PARTICIPANT

FIG 4 BREAKDOWN OF PRIMARY RESEARCH, BY DESIGNATION

FIG 5 BREAKDOWN OF PRIMARY RESEARCH, BY COMPANY TYPE

FIG 6 DATA TRIANGULATION APPROACH

FIG 7 HONG KONG WOUND DRESSING MARKET SUMMARY

FIG 8 BARGAINING POWER OF BUYERS

FIG 9 BARGAINING POWER OF SUPPLIERS

FIG 10 INTENSITY OF RIVALRY

FIG 11 THREAT OF NEW ENTRANTS

FIG 12 THREAT OF SUBSTITUTES

FIG 13 HONG KONG WOUND DRESSING MARKET SNAPSHOT

FIG 14 HONG KONG WOUND DRESSING MARKET, BY TYPE, $’000 (2025–2030)

FIG 15 HONG KONG ADVANCED WOUND DRESSING MARKET, BY TYPE, $’000 (2025–2030)

FIG 16 HONG KONG TRADITIONAL WOUND DRESSING MARKET, BY TYPE, $’000 (2025–2030)

FIG 17 HONG KONG WOUND DRESSING MARKET, BY APPLICATION, $’000 (2025–2030)

FIG 18 HONG KONG WOUND DRESSING MARKET FOR CHRONIC WOUNDS, BY TYPE, $’000 (2025–2030)

FIG 19 HONG KONG WOUND DRESSING MARKET FOR ACUTE WOUNDS, BY TYPE, $’000 (2025–2030)

FIG 20 HONG KONG WOUND DRESSING MARKET, BY END USER, $’000 (2025–2030)

FIG 21 HONG KONG MARKET FOR WOUND DRESSINGS FOR HOSPITAL AND SPECIALTY CLINIC USE, BY TYPE, $’000 (2025–2030)

FIG 22 HONG KONG WOUND DRESSING MARKET, BY DISTRIBUTION CHANNEL, $’000 (2025–2030)

FIG 23 COLOPLAST A/S – REVENUE SPLIT BY BUSINESS AREA AND GEOGRAPHY (2023)

FIG 24 3M COMPANY – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 25 PAUL HARTMANN AG – REVENUE SPLIT BY BUSINESS DIVISION AND GEOGRAPHY (2023)

FIG 26 MÖLNLYCKE HEALTH CARE AB – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 27 SMITH & NEPHEW PLC – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 28 CONVATEC GROUP PLC – REVENUE SPLIT BY FRANCHISE AND GEOGRAPHY (2023)

FIG 29 B. BRAUN MELSUNGEN AG – REVENUE SPLIT BY DIVISION AND GEOGRAPHY (2023)

FIG 30 ESSITY AB – REVENUE SPLIT BY BUSINESS AREA AND GEOGRAPHY (2023)

FIG 31 BEIERSDORF AG – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 32 JOHNSON & JOHNSON – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 33 CARDINAL HEALTH INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 34 MEDTRONIC PLC – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 35 INTEGRA LIFESCIENCES HOLDINGS CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 36 WRIGHT MEDICAL GROUP N.V. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 37 NITTO DENKO CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 38 WEIGAO GROUP CO., LTD. – REVENUE SPLIT BY PRINCIPAL PRODUCT AND GEOGRAPHY (2023)